V
Verve Therapeutics D
D
VERV
11.090
USD
-0.04
(-0.36%)
مغلق
حجم التداول
220,894
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
990,472,453
العنوان: Verve Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.